Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 80 of the 82 references it cites were found in a registry or an index.

Strategies to advance translational research into brain barriers

Abstract

There is a paucity of therapies for most neurological disorders--from rare lysosomal storage diseases to major public health concerns such as stroke and Alzheimer's disease. Advances in the targeting of drugs to the CNS are essential for the future success of neurotherapeutics; however, the delivery of many potentially therapeutic and diagnostic compounds to specific areas of the brain is restricted by the blood-brain barrier, the blood-CSF barrier, or other specialised CNS barriers. These brain barriers are now recognised as a major obstacle to the treatment of most brain disorders. The challenge to deliver therapies to the CNS is formidable, and the solution will require concerted international efforts among academia, government, and industry. At a recent meeting of expert panels, essential and high-priority recommendations to propel brain barrier research forward in six topical areas were developed and these recommendations are presented here.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(07)70326-5

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 82 references

Research works printed but not linked: 1

  1. Abbott, 2004, Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology, Neurosci Int, 45, 545

Cited by

See all 483

Metadata

Authors
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., Pardridge, W., Rosenberg, G. A., Smith, Q., & Drewes, L. R.
Affiliations
  • Oregon Health & Science University (US)
  • King's College London (GB)
  • Memorial Sloan Kettering Cancer Center (US)
  • St. Louis VA Medical Center (US)
  • University of Manitoba (CA)
  • University of Arizona (US)
  • University of Bern (CH)
  • Texas Tech University Health Sciences Center (US)
  • University of Rochester Medicine (US)
  • University of California, Los Angeles (US)
  • University of New Mexico (US)
  • University of Minnesota (US)
Corresponding author
Neuwelt, Edward
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2008-01
Volume
7
Issue
1
Pages
84-96
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2073077090
Cited by
474
References
82
Citations by year
2026: 10 · 2025: 13 · 2024: 18 · 2023: 23 · 2022: 19 · 2021: 31 · 2020: 27 · 2019: 23 · 2018: 28 · 2017: 29 · 2016: 21 · 2015: 37 · 2014: 29 · 2013: 40 · 2012: 32
FWCI
2.71
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • BORIS (University Library Bern) (submittedVersion)
Funders
National Cancer Institute (R13CA086959, 1 R13 CA86959-06)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
Keywords
blood-brain barrier, blood-CSF barrier, brain drug delivery, neurotherapeutics, translational research, lysosomal storage disease, stroke, Alzheimer's disease, research priorities, expert panel recommendations
MeSH terms
Biological Transport, Blood-Brain Barrier, Brain, Brain Diseases, Humans, Models, Biological, Drug Design, Drug Delivery Systems, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Strategies to advance translational research into brain barriers. https://app.cochat.ai/papers/10.1016/s1474-4422(07)70326-5
The paper
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., Pardridge, W., Rosenberg, G. A., Smith, Q., & Drewes, L. R. (2008). Strategies to advance translational research into brain barriers. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(07)70326-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.